Skip to main content
TipRanks
Go Ultimate75% OFF

AMA Corporation Plc (ALAMA) AI Stock Analysis

0 Followers
FR:ALAMA

AMA Corporation Plc

(Paris:ALAMA)

Select Model
Rating:40Underperform
Price Target:EUR 0.09â–¼(-19.64% Downside)
Action:downgraded
Date:10/07/26

The overall score is low because the company’s financial profile is deeply loss-making with declining revenues, negative equity, and sustained cash burn, leaving little buffer to absorb further setbacks. Technical indicators reinforce this cautious view, showing a clear downtrend with the price below all major moving averages despite an oversold reading that only hints at a potential short-term bounce. Valuation adds limited support, as a negative P/E and lack of dividend mean the stock currently has no earnings or income foundation, keeping the investment thesis high risk and dependent on future operational turnaround.

Positive Factors
Strong Gross MarginA strong gross margin provides a potentially viable economic base for the business, because each unit of revenue can contribute meaningfully before operating costs. However, the benefit will only become durable if AMA can control operating expenses and convert gross profit into operating profitability.
Negative Factors
Persistent Losses and Revenue DeclinePersistent operating and net losses, combined with continuing revenue contraction, show that AMA has not yet established a scalable path to profitability. Shrinking revenue reduces the base available to absorb fixed costs, while ongoing losses can limit reinvestment and weaken financial resilience over the next several quarters.

AMA Corporation Plc (ALAMA) vs. iShares MSCI France ETF (EWQ)

-50%-40%-30%-20%-10%0%10%20%FR:ALAMA-37.78%EWQ+2.16%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 6.02M
Dividend Yield
―
Average Volume (3M)
21.84K
Price to Earnings (P/E)
-0.8
Beta (1Y)
1.17
Revenue Growth
-20.28%
EPS Growth
22.97%
Country
France
Employees
27
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

AMA Corporation Plc Business Overview & Revenue Model

Company Description

AMA Corporation Ltd delivers remote support solutions to industrial organizations, service providers, and medical institutions across the globe. The company develops its XpertEye assisted reality platform, which facilitates applications like remote g...

How the Company Makes Money

null

AMA Corporation Plc Financial Statement Overview

Summary

Financial performance is very weak: revenues have declined for several years, losses are large and persistent, equity turned negative in 2025, and cash flows remain consistently negative, although loss and cash burn reduction since 2022 provide a modest positive offset.

Income Statement

24Negative

Balance Sheet

18Very Negative

Cash Flow

30Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.99M1.99M2.49M3.01M4.28M6.57M
Gross Profit1.42M1.42M1.97M-688.00K4.90M8.04M
EBITDA-4.99M-4.99M-6.36M-6.87M-10.27M-6.52M
Net Income-5.67M-5.67M-7.34M-8.04M-21.39M-9.84M
Balance Sheet
Total Assets4.43M4.43M9.17M12.75M13.65M38.22M
Cash, Cash Equivalents and Short-Term Investments2.09M2.09M5.82M9.39M8.60M20.64M
Total Debt2.79M2.79M4.03M3.96M4.53M4.70M
Total Liabilities5.37M5.37M6.62M6.97M7.85M11.32M
Stockholders Equity-991.00K-991.00K2.50M5.71M5.68M27.29M
Cash Flow
Free Cash Flow-4.84M-4.84M-6.39M-5.79M-13.00M-10.28M
Operating Cash Flow-4.80M-4.80M-6.28M-5.74M-10.52M-5.10M
Investing Cash Flow37.00K37.00K114.00K149.00K-1.24M-5.22M
Financing Cash Flow1.06M1.06M2.59M6.46M-293.00K29.67M

AMA Corporation Plc Technical Analysis

Technical Analysis SentimentNeutral
Last Price0.11

Price Trends

50DMA0.13Negative
100DMA0.14Negative
200DMA0.13Negative

Market Momentum

MACD-0.00Negative
RSI48.78Neutral
STOCH59.80Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALAMA, the sentiment is Neutral. The current price of 0.11 is above the 20-day moving average (MA) of 0.10, below the 50-day MA of 0.13, and below the 200-day MA of 0.13, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 48.78 is Neutral, neither overbought nor oversold. The STOCH value of 59.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:ALAMA.

AMA Corporation Plc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

FR:ALAMA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:ALERSFR:ALERS58NeutralEUR 259.38M37.713.89%―6.28%204.56%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
FR:ALIKOFR:ALIKO46NeutralEUR 22.89M-5.31-22.49%―37.28%7.83%
FR:ALMDTFR:ALMDT43NeutralEUR 213.68M-3.54271.64%―2.16%-5.26%
FR:ALAMAFR:ALAMA40UnderperformEUR 6.02M-0.75――-20.28%22.97%

* Healthcare Sector Average

Performance Comparison

0%100%200%FR:ALAMAFR:ALERSFR:ALDMSFR:ALIKOFR:ALMDTFR:ALBIODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
FR:ALAMA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FR:ALAMAAMA Corporation Plc0.11-0.07-37.78%
FR:ALERSEurobio-Scientific SA26.401.556.24%
FR:ALDMSDiagnostic Medical Systems0.90-0.38-29.69%
FR:ALIKOIkonisys SA1.45-0.01-0.68%
FR:ALMDTMedian Technologies4.361.4047.30%
FR:ALBIOBiosynex SA0.820.3160.78%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 07, 2026